baber/WOPTO huggingface dataset:
Patent NZ-509812-A (NZ)
Title: System for transmitting messages via a low-voltage power supply network and adapter
Inventor: WIDMER HANSPETER
IPC: H01R13/719
Filed: 1999-07-14
Abstract: The arrangement transmits the messages using frequencies in the range of 1 to 40 MHz. The arrangement has a device for receiving or transmitting data with a frequency significantly higher than the mains frequency. The device is connected to the low voltage supply network via a plug inserted into a mains socket. At least one device not for data exchange representing a potential noise source, is also connected via a plug. The mains plugs (11') and sockets (12') are connected via intermediate parts (1), each with a plug connected to the socket for the potential noise source and at least one socket with which the device is connected via a plug. The intermediate part has parallel conductor connections for the individual conductors of the low voltage supply network (9). An inductance is present in each conductor connection apart from the earth conductor connection. An Independent claim is also included for an intermediate part for use in an arrangement for transmitting messages via a low voltage power supply network.
Patent NZ-511399-A (NZ)
Title: Methods and compositions for the prevention of tolerance to asthma medications using a bronchodilator and a polysaccharide effector such as heparin
Inventor: AHMED TAHIR
IPC: A61K31/215
Filed: 1999-10-13
Abstract: The identification of moieties and the use of the same for preventing tolerance to bronchodilators are described. More specifically, described is the identification of compositions and methods, which are capable of preventing tolerance to beta 2-adrenergic agonists. The methods and compositions are also useful as analytical tools for functional studies and as combination therapeutic tools. Figure 2 is a graphic representation showing the ability of a representative bronchodilator (salmeterol) used in conjunction with representative effectors (low molecular weight heparin preparations) to prevent tolerance to bronchodilators in a heparin-nonresponsive patient. The first dose of salmeterol caused a marked increase in PD20-methacholine on day 1, showing bronchoprotection. Lesser bronchoprotection was observed after the 3rd-7thdoses of salmeterol (days 2-4), indicating development of tolerance. As shown, tolerance was prevented by inhaled low molecular weight heparin.
Patent NZ-512191-A (NZ)
Title: Fungicidal mixtures and process for controlling harmful fungi thereof
Inventor: SCHELBERGER KLAUS
IPC: A01N47/24
Filed: 1999-11-06
Abstract: A fungicidal mixture comprising: (a) a carbamate of the formula (I) in which X is CH or N, n is 0, 1 or 2 and R is halogen, C1-C4-alkyl or C1-C4-haloalkyl, where the radicals R can be different if n is 2, and (b) a copper-containing fungicidal active compound (II) in a synergistically active amount is disclosed. A process for controlling harmful fungi, which comprises treating the harmful fungi, their habitat or plants, seeds, soil, areas, materials or spaces to be kept free from with synergistically effective amounts of the compound of formula (I) or a salt or adduct thereof and the compound (II) is also disclosed.
Patent NZ-513292-A (NZ)
Title: Process to prepare cyclic-sulfur fluorine containing oxazolidinones
Inventor: GAGE JAMES R
IPC: C07D413/10
Filed: 2000-01-31
Abstract: The preparation of cyclic-sulfur fluorine containing oxazolidinone antibacterial agents by reaction of the 4-bromo-3-fluorinated carbamate with tetrahydrothiopyran-4-one to produce a tetrahydrothiopyran-o-fluorinated compound (IV), where Rester is selected from the group consisting of: (I) C1-C10 alkyl optionally substituted with: (A) phenyl, (B) 1 to 3 C1-C3 alkoxy, (II) C2-C5 alkenyl optionally substituted with: (A) phenyl, (B) C3-C7 cycloalkyl, (III) phenyl optionally substituted with one to three C1-C3 alkyl (IV) naphthyl optionally substituted with one to three C1-C3 alkyl The tetrahydrothiopyran-o-fluorinated compound (IV) is a key intermediate to making oxazolidinone antibacterial agents which contain the tetrahydrothiopyran-o-fluorinated group.
Patent NZ-514798-A (NZ)
Title: A machine and method for applying a coating
Inventor: HUNTER JOSEPH
IPC: B29C43/56
Filed: 2000-05-04
Abstract: A machine (10) for applying a sheet-like film (23) to the surface of an object.  The machine (10) includes a deck (11) and a hood (12) which are movable relative to one another from a loading position in which an object (21) to which the film (23) is to be applied can be placed on the deck (11), to an operative position for application of the film (23) to the object.  The hood (12) includes heating means to heat the film (23) and the deck (11) and the hood (12) being sealingly engaged in the operative position to define a vacuum chamber therebetween.  In use, the film (23) for application to the object (21) is positioned to overlie the object (21) and to separate the chamber into upper and lower sub-chambers (29, 30) above and below the film (23).  The machine (10) is operable to generate substantially equal vacuum in each of the sub-chambers (29, 30) and to release the vacuum generated in the upper sub-chamber (29) to cause the film (23) to be pressed into engagement with the object (21) under the influence of the greater pressure in the upper sub-chamber (29).
Patent NZ-516341-A (NZ)
Title: Texture masked particles comprising an active ingredient coated with a film forming polymer and an anti-grit agent
Inventor: PARIKH NARENDRA
IPC: A61K9/50
Filed: 2001-12-21
Abstract: A texture masked particle comprises: a core containing an active ingredient such as an nonsteroidal anti-inflammatory drug; a first coating layer comprising a taste masking agent that substantially covers the core such as a mixture of a enteric polymer and a insoluble film forming polymer; a second coating layer on the surface on the first coating layer comprising a film forming polymer and an anti-grit agent such as polyethylene oxide or polyethylene glycol. A texture masked particle comprises: a core containing an active ingredient such as an nonsteroidal anti-inflammatory drug; a texture masking coating layer on the surface on the core comprising a film forming polymer and an anti-grit agent such as polyethylene oxide or polyethylene glycol. A texture masked particle comprises a matrix of: an active ingredient such as an nonsteroidal anti-inflammatory drug; a film forming polymer and an anti-grit agent such as polyethylene oxide or polyethylene glycol where the film forming polymer and the anti-grit agent are exposed at the surface of the particle in an amount effective for texture masking of the active ingredient.
Patent NZ-517688-A (NZ)
Title: Smoke activated power isolator
Inventor: FARQUHAR KEVIN DESMOND
IPC: H01H47/22
Filed: 2002-03-08
Abstract: A hazard prevention module 1 includes a housing mountable on a switchboard, such as to a DIN rail on the board, power input terminals 4, 5, a signal input terminal 7, a reset button 2 and indicator LED 3, and contactor terminals 10, 11.  When a voltage signal from an activated smoke alarm is received on terminal 7, holding power is removed from the contactor terminals 10, 11 so that the contactor switches off the power supply to the appliance that is the energy source for the fire that has activated the smoke alarm.  The module can be reset by push button 2 or remotely reset by signal supplied to terminals 8, 9.
Patent NZ-521443-A (NZ)
Title: Improved storage tank assembly
Inventor: BOUDRY JOHN ALEXANDRE
IPC: B65D90/503
Filed: 2001-03-16
Abstract: According to the present invention there is provided a storage tank assembly comprising: (i) a storage tank; (ii) support means comprising at least one load bearing reinforcement means extending around and attached to at least a portion of the outer circumference of the storage tank, the support means further incorporating at least one mounting leg to enable the support means to be connected to a canopy.
Patent NZ-524942-A (NZ)
Title: Method and apparatus and screen for screening mechanical fibre pulp
Inventor: HAUTALA JOUKO
IPC: D21D5/02
Filed: 2001-10-16
Abstract: A method of screening mechanically manufactured fibre pulp mixture by mechanically defibering wood in the presence of water and then screening into at least two fractions containing fibres of different lengths. The method of screening is characterised by at least one screening phase where the fibre pulp mixture or part thereof is screened to separate short fibres. Screening is accomplished by using a gap screen comprising a convergent gap (13) and at least one wire (shown two wires 11 and 12) restricting the gap. The fibre pulp mixture (18) to be screened or part thereof is fed into the convergent gap and flows in the same direction as the wire towards an output port (22) at the convergent end of the gap, the short fibres and some of the water fed into the gap exit through the openings in the wire, the water and the remaining fibre pulp mixture exit through the output port of the gap.
Patent NZ-528769-A (NZ)
Title: End portions for a flexible fluid containment vessel and a method of making the same
Inventor: EAGLES DANA
IPC: B65D88/16
Filed: 2002-04-05
Abstract: A containment vessel fabricated out of fabric for transporting and containing a large volume of fluid. Particularly fresh water, having tapered front and/or rear portions formed out of the intermediate tubular structure, including a method of making the same.
Patent NZ-529381-A (NZ)
Title: Frictional damper for damping movement of structures
Inventor: MUALLA IMAD H
IPC: E04H9/02
Filed: 2002-05-09
Abstract: A device for damping the relative movement of a first structural member in relation to a second structural member, the first structural member being rotationally joined to at least two elements of a first group of elements, and the second structural member being rotationally joined to at least two elements of a second group of elements, wherein each of the at least two elements is joined to the structural members, respectively, by means of a joint fixating one end of the element relatively to the structural member while allowing rotation of the element, and wherein each of the elements of the first group of elements are individually joined to an element of the second group of elements in a rotational joint, so as to form at least six rotational joints for damping relative movement between the elements of the first group of elements and the elements of the second group of elements and thus for damping the movement of the first structural member in relation to the second structural member, and wherein at least one of said rotational joints includes a damping member.
Patent NZ-530118-A (NZ)
Title: Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperindinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenzene acetic acid and its hydrochloride
Inventor: REDDY M SATYANARAYANA
IPC: C07D211/22
Filed: 2001-07-31
Abstract: Disclosed is crystalline form A of fexofenadine, 4-[4-[4-(hydroxydiphenylmethyl)-1-piperindinyl]-1-hydroxybutyl]-alpha,alpha-dimethylbenzene acetic acid having a melt endotherm with a peak temperature of 227-231 degrees Celsius and a process for its preparation. Further disclosed is an anhydrous crystalline Form X of fexofendaine hydrochloride 4-[4-[4-(hydroxydiphenylmethyl)-1-piperindinyl]-1-hydroxybutyl]-alpha,alpha-dimethylbenzene acetic acid having a melt endotherm with a peak temperature of 184-189 degrees Celsius and a process for the preparation thereof in which crystalline form A may be utilised.
Patent NZ-532309-A (NZ)
Title: Garden tool rack
Inventor: LIN PEI-YING
IPC: A47F5/00
Filed: 2004-04-16
Abstract: A garden tool rack, having a body with a plurality of plugholes vertically extended through the top and bottom walls. Bottom barrels extend downward from the bottom wall around the plugholes. Tool holders are fastened to each plughole for holding garden tools. End caps can be fastened to the bottom of the barrels and a plurality of anchoring devices are respectively coupled to the end caps and used to anchor the rack body to the earth.
Patent NZ-532429-A (NZ)
Title: Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder
Inventor: SENNEF CORNELIS
IPC: A61P25/24
Filed: 2002-10-21
Abstract: Disclosed is a pharmaceutical preparation comprising a daily dosage unit of (11â,17â)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(propynyl)estra-4,9-dien-3-one of between 150 mg and 300 mg, and the use of the preparation for the manufacture of a medicament for the treatment of a patient suffering from a major depressive disorder.
Patent NZ-533388-A (NZ)
Title: Adjustable adapter for gravity-feed paint sprayer
Inventor: GOSIS ANATOLY
IPC: B05B7/24
Filed: 2004-06-08
Abstract: An adjustable adapter includes two arms, each having an axis, a surface substantially normal to the axis, wherein the surfaces of the arms face each other, an end and a passageway for fluid communication between the end and the opening, wherein one of the arm ends is for connection to an inlet of an applicator and the other arm end is for connection to an outlet of a container, and a fastener for pivotally coupling the arms. One of the arm surfaces is provided with a groove in fluid communication with both arm openings. The groove is sealed to prevent fluid from leaking from between the surfaces. When the fastener is in a rotation-resisting mode, the fastener forces the surfaces of the arm toward one another sufficiently to increase friction and resist rotation therebetween, and when the fastener is in a rotation-permitting mode, the fastener releases the surfaces sufficiently to decrease friction and permit rotation therebetween.
Patent NZ-534453-A (NZ)
Title: Blister pack device
Inventor: BENKTZON MARIA
IPC: A61J7/00
Filed: 2003-02-24
Abstract: A blister pack device (1) for storing a blister pack (12) and dispensing a dosage unit (15) therefrom is disclosed, wherein the device comprises a container (2) having an opening (4) for receiving the blister pack, wherein the container is provided with a dispensing means (6,8, 9) for ejecting a dosage unit from a blister (13) of the blister pack, the dispensing means comprises a lever arm (6) pivotally mounted on the container and a cavity (8) in the container for receiving an ejected dosage unit wherein the lever arm has a first open position allowing the blister pack to be positioned under the lever arm and a second lowered position for ejecting the dosage unit from the blister into the cavity.
Patent NZ-535204-A (NZ)
Title: Method for adjusting the fibrous properties of pulp
Inventor: RANUA JUKKA
IPC: B07C5/14
Filed: 2003-03-21
Abstract: The invention relates to a method for adjusting the fibrous properties of chemical pulp, mechanical pulp or chemi-mechanical pulp, for adjusting the smoothness of the properties and for decreasing any variation in quality. According to the method, in the manufacture of pulp, a wood material is used, which is selected according to the number of the tree's annual rings. The wood material is classified according to the number of annual rings into categories that represent a certain fibre dimension property, such as the fibre length or the fibre coarseness. The wood material is classified by log or group of logs at any stage in connection with the felling of the wood or in the plant or at some stage of the chain between the stub and pulping and grinding or a refiner.
Patent NZ-536261-A (NZ)
Title: Vaginal care composition
Inventor: VOLKMANN PETER-HANSEN
IPC: A61K33/30
Filed: 2004-10-28
Abstract: A vaginal care composition, comprising viable Lactobacillus and/or Bifidobacterium microorganisms, preferably Lactobacillus bifidus; non-viable Saccharomyces cultures, preferably Saccharomyces cerevisiae; saccharides; vitamin A/retinol; and zinc; a cream, tampon, ovule or panty liner comprising the composition; and the use of the composition for the care of the vaginal mucosa and for preventing infections thereof by bacteria, fungi and/or viruses.
Patent NZ-537062-A (NZ)
Title: Device for processing the surface of objects
Inventor: VETTER THOMAS
IPC: B41F17/22
Filed: 2003-06-06
Abstract: The disclosure relates to a device (1) for processing the surface of objects (3), and comprises a predetermined number of processing stations (B1-B8) which carry out a given sequence of processing processes and a conveying unit performing processing movements. The objects are conveyed to predefined desired positions at the processing stations (B1-B8) by means of the conveying unit. The device also includes a central control unit (7), by means of which the processing movements of the conveying unit and the processing processes of the processing stations are synchronized, by presetting a clock pulse which controls each processing process and correlates the processing movements of the object that is to be processed for each processing station (B1-B8) via the central control unit.
Patent NZ-538333-A (NZ)
Title: Chewable veterinary formulations, which do not contain animal products or flavours derived from animal sources, that exhibit organoleptic properties that the animal finds appealing
Inventor: HAGENBUCH MICHELLE
IPC: A23K20/195
Filed: 2003-08-14
Abstract: Provided is a chewable veterinary formulation, which does not contain animal products, which comprises: -effective amount of at least one pharmaceutical agent; - at least one filler -at least one disintegrant; -at least one non-animal product containing flavour or flavour derived from a non-animal source; -at least one binder; -at least one humectant; -at least one granulating solvent; and -optionally, at least one antioxidant, at least one buffering agent, at least one preservative, or at least one colorant. The pharmaceutical agent is a compound selected from a group consisting of antiparasitic agents, nordulisporic acid and its derivatives, estrogens, progestins, androgens, substituted pyridyl methyl derivatives, phenylpyrazols, COX-2 inhibitors and proton pump inhibitors. Further provided is a process of producing chewable veterinary formulations as well as to a method for enhancing the patentability of oral veterinary formulations to an animal by adding a smoke hickory flavour to the formulation.
Patent NZ-544717-A (NZ)
Title: Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing said mixtures
Inventor: LAUX VOLKER
IPC: C08B37/10
Filed: 2004-07-22
Abstract: Disclosed are heparin-derived oligosaccharide mixtures, having an average molecular weight from 1,800 to 2,400 daltons. The oligosaccharide mixtures have the general structure of the constituent polysaccharides of heparin and have an anti-Xa activity of between 190 IU/mg and 450 IU/mg and an anti-IIa activity of less than 0.2 IU/mg. The constituent oligosaccharides of the mixtures contain from 2 to 16 saccharide units, have a 4,5-unsaturated uronic acid 2-O-sulfate unit at one of their ends, and contain the hexasaccharide of the depicted formula, in the form of an alkali metal or alkaline-earth metal salt. Also disclosed is the preparation method thereof and to the pharmaceutical compositions containing said mixtures.
Patent NZ-545037-A (NZ)
Title: Methods for administering aripiprazole
Inventor: BROWN JOSIAH
IPC: A61K47/38
Filed: 2004-07-29
Abstract: Disclosed is an injectable composition for the extended release of aripiprazole comprising a mixture of at least about 10 mg/ml aripiprazole in an injection vehicle that is free of sustained release matrices comprising an optional viscosity enhancing agent. Also disclosed is a composition comprising at least about 10 mg of aripiprazole and an aqueous injection vehicle comprising water, a viscosity enhancing agent, a wetting agent and a tonicity agent.
Patent NZ-548187-A (NZ)
Title: A touch switch system for a bath or pool
Inventor: BLOXHAM STEVE
Filed: 2006-06-28
Abstract: A bath or pool (10) including an unitary bath or pool shell a capacitive switch (26) on the rear side of a wall section of the bath or pool shell or the under side of an integral rim of the bath or pool shell and a marking (26) on a front surface of the wall section of the bath or pool shell or integral rim opposite the capacitive switch. The capacitive switch is mounted to the wall section or integral rim without forming an aperture ion the wall section or rim of the bath or pool. The capacitive switch and bath or pool shell and the marking are all arranged so that touching the front surface of the bath or pool shell or integral rim at the marking operates the capacitive switch on the rear side of the bath or pool shell to switch a function associated with the bath or pool.
Patent NZ-552476-A (NZ)
Title: Tumor specific antibody
Inventor: GLOVER NICHOLAS RONALD
IPC: A61K38/17
Filed: 2005-06-10
Abstract: Disclosed is an isolated complementarity determining region (CDR) selected from the group consisting of: a light chain complementarity determining region 1 (CDR1) comprising the amino acid sequence of SEQ ID NO:1; a light chain complementarity determining region 3 (CDR3) comprising the amino acid sequence SEQ ID NO:3; a heavy chain complementarity determining region 1 (CDR1) comprising the amino acid sequence SEQ ID NO:4; a heavy chain complementarity determining region 2 (CDR2) comprising the amino acid sequence SEQ ID NO:5; and a heavy chain complementarity determining region 3 (CDR3) comprising the amino acid sequence SEQ ID NO:6.
Patent NZ-553263-A (NZ)
Title: Insulin-oligomer conjugates, formulations and uses thereof
Inventor: RADHAKRISHNAN BALASINGAM
IPC: C07K14/62
Filed: 2005-07-19
Abstract: Disclosed is a complex comprising: an insulin conjugate comprising a native insulin or polypeptide analog thereof conjugated to a modifying moiety, wherein the polypeptide analog exhibits similar activity relative to the native insulin, and wherein the modifying moiety comprises a polyalkyleneglycol (PAG) component and an alkyl component; and a cation, wherein the insulin conjugate is complexed to a divalent Group II or transition metal cation. The disclosure also relates to solids and pharmaceutical compositions including such complexes, methods of making such complexes, and methods of using such complexes in the treatment of insulin compound deficiencies and other ailments or diseases such as diabetes.
Patent NZ-553327-A (NZ)
Title: Modulators of hepatocyte growth factor activator
Inventor: KIRCHHOFER DANIEL K
IPC: A61K39/395
Filed: 2005-10-03
Abstract: Provided is an isolated antibody that specifically binds human hepatocyte growth factor activator (HGFA) wherein the antibody binds to HGFA at a position outside of the protease domain. Further provided are such antibodies with specified sequences and uses of the antibodies in the manufacture of a medicament for treating pathological conditions associated with c-met activation.
Patent NZ-565193-A (NZ)
Title: Carboxymethylated cellulosic wound dressing garment
Inventor: GRIFFITHS BRYAN
IPC: A61F13/14
Filed: 2006-06-30
Abstract: A body shaped wound dressing comprises a knitted garment, with an outer surface knitted from textile yarn and the inner wound connecting surface from cellulosic yarn, and where the inner surface has been at least partially carboxymethylated.